X
May 19, 2021 08:26 PM (GMT+8) · EqualOcean
Kechuangban Daily reported on the 19th that a reporter of kechuangban daily learned from the industry that yixinwei medical, a domestic Neurointerventional head enterprise, is currently involved in a patent dispute with Medtronic, a multinational device manufacturer, and the IPO process of Hong Kong stocks may be affected. Xinwei medical has submitted an application for listing on the Hong Kong Stock Exchange on January 27 this year. According to the results of tianyancha, Medtronic, as the plaintiff, filed a "related infringement of invention patent dispute" with Xinwei medical, and the case was heard on May 11.